-
公开(公告)号:US20240350259A1
公开(公告)日:2024-10-24
申请号:US18686816
申请日:2022-08-26
申请人: BIOTUBE CO., LTD.
发明人: Yasuhide NAKAYAMA
CPC分类号: A61F2/2415 , A61F2/062 , A61F2240/001
摘要: Disclosed is a tissue body formation device for forming a connective tissue body in an environment in which a living tissue material is present. The device includes a partition wall that defines a hollow space for forming the connective tissue body from the living tissue material. An exterior portion of the partition wall that separates the environment from the hollow space includes through-holes that extend between the environment and the hollow space. The through-holes have an opening size of 0.02 mm or greater and 2.5 mm or less. A section of the connective tissue body that includes dense connective tissue is a dense section. A surface of the partition wall that is in contact with the dense section includes non-degradable resin. The non-degradable resin has a compressive strength of 10 MPa or greater and 60 MPa or less and a contact angle with water of 90° or greater.
-
2.
公开(公告)号:US12115281B2
公开(公告)日:2024-10-15
申请号:US18068168
申请日:2022-12-19
发明人: Joseph P. Vacanti
CPC分类号: A61L27/3808 , A61F2/062 , A61L27/507 , A61L27/52 , C12M21/08 , C12M25/10 , C12M25/14 , C12N5/0671 , C12N2533/50
摘要: A platform for creating engineered tissues includes a vascular tube that defines a vascular diameter and is configured to receive vascular system seed cells, a non-vascular tube that defines a non-vascular tube diameter and is configured to receive organ system seed cells, and a barrier formed between the vascular tube and the non-vascular tube.
-
公开(公告)号:US20240156491A1
公开(公告)日:2024-05-16
申请号:US18484221
申请日:2023-10-10
申请人: INTERVENE, INC.
发明人: Fletcher T. Wilson , Douglas Sutton , Christopher Scott Jones , Benjamin K. Cline , Mariel Fabro
CPC分类号: A61B17/3417 , A61B1/3137 , A61B17/00234 , A61B17/06166 , A61B17/3403 , A61B17/3478 , A61F2/06 , A61F2/062 , A61F2/2415 , A61F2/2475 , A61B17/32037
摘要: Medical systems, devices and methods for creation of autologous tissue valves within a mammalian body are disclosed. One example of a device for creating a valve flap from a vessel wall includes an elongate tubular structure having a proximal portion and a distal portion and a longitudinal axis; a first lumen having a first exit port located on the distal portion of the elongate tubular structure; a second lumen having a second exit port located on the distal portion of the elongate tubular structure; a recessed distal surface on the distal portion of the elongate tubular structure, wherein the recessed distal surface is located distally to the first exit port; and an open trough on the recessed distal surface extending longitudinally from the first exit port.
-
公开(公告)号:US20230277293A1
公开(公告)日:2023-09-07
申请号:US18117930
申请日:2023-03-06
发明人: Robert Tranquillo , Zeeshan Syedain , Lee Meier
CPC分类号: A61F2/06 , A61F2/04 , A61F2/2412 , B29D23/00 , A61L27/3695 , A61L27/3604 , A61F2/2415 , A61L27/36 , A61L27/507 , A61L27/3633 , A61F2/062 , A61L2430/40
摘要: This disclosure describes decellularized, biologically-engineered tubular grafts and methods of making and using such decellularized, biologically-engineered tubular grafts.
-
公开(公告)号:US11648103B2
公开(公告)日:2023-05-16
申请号:US16215690
申请日:2018-12-11
发明人: Bernhard Winkler , Martin Grapow , Friedrich Eckstein , Aldo Ferrari , Dimos Poulikakos , Simone Bottan , Maximilian Fischer , Tobias Lendenmann
CPC分类号: A61F2/07 , A61F2/06 , A61F2/062 , A61F2/90 , A61F2002/0086 , A61F2002/068 , A61F2002/072 , A61F2210/0014 , A61F2210/0076 , A61F2250/003 , A61F2250/0026 , A61F2250/0051 , A61F2310/00011 , A61F2310/00982 , C12N1/20
摘要: The invention relates to an artificial vascular graft comprising a primary scaffold structure encompassing an inner space of the artificial vascular graft, said primary scaffold structure having an inner surface facing towards said inner space and an outer surface facing away from said inner space, a coating on said inner surface, wherein a plurality of grooves is comprised in said coating of said inner surface. The primary scaffold structure comprises further a coating on said outer surface. The primary scaffold structure and the coating on said inner surface and on said outer surface are d designed in such a way that cells, in particular progenitor cells, can migrate from the periphery of said artificial vascular graft through said outer surface of said coating, said primary scaffold structure and said inner surface to said inner space, if the artificial vascular graft is used as intended. The invention relates further to a method for providing said graft.
-
公开(公告)号:US20180256312A1
公开(公告)日:2018-09-13
申请号:US15800687
申请日:2017-11-01
CPC分类号: A61F2/062 , A61F2/022 , A61F2/04 , A61F2/06 , A61F2002/068 , G01N33/5008
摘要: The invention provides method of fabricating a scaffold comprising a fluidic network, including the steps of: (a) generating an initial vascular layer for enclosing the chamber and providing fluid to the cells, the initial vascular layer having a network of channels for fluid; (b) translating the initial vascular layer into a model for fluid dynamics analysis; (c) analyzing the initial vascular layer based on desired parameters selected from the group consisting of a characteristic of a specific fluid, an input pressure, an output pressure, an overall flow rate and combinations thereof to determine sheer stress and velocity within the network of channels; (d) measuring the sheer stress and the velocity and comparing the obtained values to predetermined values; (e) determining if either of the shear stress or the velocity are greater than or less than the predetermined values, and (f) optionally modifying the initial vascular layer and repeating steps (b)-(e). The invention also provides compositions comprising a vascular layer for use in tissue lamina as well as a medical devices having a vascular layer and kits.
-
公开(公告)号:US09932559B2
公开(公告)日:2018-04-03
申请号:US13679510
申请日:2012-11-16
发明人: Andrew D. Wong , Peter C. Searson
CPC分类号: C12N5/0691 , A61F2/062 , C12M21/08 , C12M25/10 , C12M25/14 , C12M29/10 , C12N5/0068 , C12N5/069 , C12N2533/30 , C12N2533/90
摘要: A platform for creating an artificial blood brain barrier including a functional, perfused artificial vessel lined with endothelial cells embedded in a physiologically relevant three-dimensional extracellular matrix is described.
-
公开(公告)号:US20180064527A1
公开(公告)日:2018-03-08
申请号:US15697607
申请日:2017-09-07
IPC分类号: A61F2/06 , C12N5/0793
CPC分类号: A61F2/062 , C12N5/0619 , C12N5/0691 , C12N2502/081 , C12N2502/086 , C12N2502/28 , C12N2533/30 , C12N2533/50 , C12N2533/52 , C12N2533/54 , C12N2533/80 , C12N2533/90
摘要: Synthetic human blood vessels can be constructed using human brain derived endothelial cells and incorporated into a tissue model that contains astrocytes and other neurons and microglia. Multi-cell type microvessels incorporate cell types such as astrocytes and pericytes in order to construct a highly representative blood-brain barrier in vitro model with a functional lumen containing brain-derived microvascular endothelial cells and a polymer wall containing human astrocytes and/or pericytes.
-
公开(公告)号:US09670450B2
公开(公告)日:2017-06-06
申请号:US14642824
申请日:2015-03-10
申请人: Purpose Co., Ltd.
发明人: Setsuo Watanabe
摘要: A cultivation apparatus and a cultivation method of a culture such as a cell or tissue. Provided are an incubator unit for accommodating a culture and a lever that penetrates through the incubator unit and can move in circular arc around a fulcrum as a center, the fulcrum being set at a wall of the incubator unit or in the vicinity thereof, then displacement is imparted to the culture by operating the lever. Bending force can be acted on the culture (cell construct) such as a cell or tissue, so that without any increase or decrease of a culture fluid in the incubator unit, namely, without any increase or decrease of pressure to the culture fluid, displacement required for cultivation can be imparted to the culture in the incubator unit. By curving, continuous compression and extension are generated in a direction of thickness from a concave portion to a convex portion of the curving.
-
公开(公告)号:US09433706B2
公开(公告)日:2016-09-06
申请号:US14723727
申请日:2015-05-28
申请人: NOVAHEP AB
IPC分类号: C12N5/00 , C12N5/02 , A61L27/50 , A61K35/44 , C12N5/071 , A61L27/36 , A61L27/38 , A61K35/14 , A61K35/28 , A61K35/34 , A61K35/545 , C12N5/078 , A61K35/12 , A61F2/06
CPC分类号: A61L27/507 , A61F2/06 , A61F2/062 , A61F2240/001 , A61K35/14 , A61K35/28 , A61K35/34 , A61K35/44 , A61K35/545 , A61K2035/124 , A61L27/24 , A61L27/3616 , A61L27/3625 , A61L27/3808 , A61L27/3826 , A61L27/3834 , A61L27/3886 , A61L27/54 , A61L2300/252 , A61L2300/64 , A61L2430/34 , C12N5/0641 , C12N5/0691 , C12N5/0692 , C12N2533/54 , C12N2533/90
摘要: The present invention relates to methods for recellularization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
-
-
-
-
-
-
-
-
-